文献速递鼻科

人工智能在慢性鼻窦炎中的作用:范围综述

The Role of Artificial Intelligence in Chronic Rhinosinusitis: A Scoping Review.
PubMed 文献 · Int Forum Allergy Rhinol · 2025-12-11

该范围综述检索Ovid MEDLINE、Ovid EMBASE、Web of Science和Cochrane Library自建库至2024年4月的文献,筛选573条记录后纳入49项研究,定性分析AI在慢性鼻窦炎(CRS)诊断与管理中的应用。常用AI形式包括深度学习(36.7%)、神经网络(24.5%)、卷积神经网络(10.2%)和随机森林模型(6.1%);55%研究聚焦诊断,29%预测预后,12%评估治疗反应或辅助治疗计划。结论认为AI在CRS管理中前景可期但仍处早期,手术规划、经济评价和交互式临床工具方面研究较少。

要点

  • AI在CRS的应用以诊断为主(55%),其次为预后预测(29%)和治疗反应评估(12%)。
  • 常用模型包括深度学习(36.7%)、神经网络(24.5%)、卷积神经网络(10.2%)和随机森林(6.1%)。
  • 训练变量涵盖CT影像、嗜酸性粒细胞计数、临床人口学特征、组织病理、细胞因子和鼻内镜所见。

核心结论

  • AI是CRS管理中有前景的工具,但仍处于早期阶段,在诊断、亚型分型和预后方面已有显著进展。

研究设计与样本

  • 范围综述,检索Ovid MEDLINE、Ovid EMBASE、Web of Science和Cochrane Library自建库至2024年4月的文献。
  • 筛选573条记录,最终纳入49项研究,按AI类型、研究目标、应用、训练变量和准确性报告进行定性分析。
  • 排除非英语文献、2003年前发表、急性鼻窦炎及儿科人群研究。

主要发现

  • 深度学习占36.7%,神经网络占24.5%,卷积神经网络占10.2%,随机森林模型占6.1%。
  • 55%的研究将AI用于CRS诊断,29%用于预测预后,12%用于评估治疗反应或辅助治疗计划。
  • 37%的研究旨在识别诊断或预后相关的生物标志物或临床变量,33%用于CRS亚型分型,20%用于评估影像学特征。
  • 训练变量包括CT影像、组织或血液嗜酸性粒细胞计数、临床或人口学特征、组织病理学特征、血液和组织细胞因子及鼻内镜所见。
  • 模型性能采用分类指标和回归指标评估。

临床怎么用

  • AI当前主要用于CRS诊断、亚型分型和预后预测,可作为耳鼻咽喉科医生临床决策的辅助工具。
  • 手术规划、经济评价和交互式临床工具方面的AI应用研究较少,临床落地需谨慎。

局限性

  • AI在CRS中的应用仍处于早期阶段,手术规划、经济评价和交互式临床工具相关研究较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the modern medical landscape, artificial intelligence (AI) is becoming an increasingly common tool for the diagnosis and management of chronic pathologies. Chronic rhinosinusitis (CRS) comprises a significant part of the practice of otolaryngology and thus provides ample opportunity for AI optimization of diagnosis and management. OBJECTIVE: With increasing interest in AI, this scoping review aims to map the current landscape of AI applications in CRS, identifying trends, gaps, and future opportunities. METHODS: A comprehensive literature search was performed in the following databases from inception-April 2024: Ovid MEDLINE, Ovid EMBASE, Web of Science, and The Cochrane Library. Studies retrieved were then screened for eligibility. The inclusion criteria included studies whose methods included the use of any form of AI for the diagnosis or management of chronic rhinosinusitis. Any studies that were non-English language publications, publications older than 2003, studies analyzing acute rhinosinusitis, and studies involving pediatric populations were excluded. Discrepancies were resolved by consensus. RESULTS: 573 records were screened, with 49 studies included in the final review. The studies were qualitatively analyzed according to the type of AI used, study objectives, application of AI, training variables for AI in CRS, and AI accuracy reporting. Commonly used forms of AI included deep learning (36.7%), neural networks (24.5%), convolutional neural networks (10.2%), and random forest models (6.1%). The majority (55%) of studies were focused on applying AI to the diagnosis of CRS. The remaining studies used AI to predict prognostic outcomes in CRS (29%) and to assess patient response to treatment or inform patient treatment plans (12%). Some studies aimed to identify biomarkers or clinical variables for the diagnosis or prognosis of CRS (37%), while others used AI to subtype CRS (33%) or assess radiologic characteristics using AI (20%). CT imaging, tissue or blood eosinophil counts, clinical or demographic patient characteristics, histopathology characteristics, blood and tissue cytokines, and nasal endoscopy findings were all variables used to train the AI models. Classification metrics and regression metrics were used to assess AI model performance. CONCLUSIONS: AI is a promising tool in the management of CRS, though it remains in its early stages. Current applications show significant progress in diagnosis, subtyping, and prognosticating in CRS, but there are few studies that analyze the utility of AI for surgical planning, economic evaluation, or interactive clinical tools. This review underscores the potential of AI for transforming an otolaryngologist's approach to CRS.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Pereira NM, Wie SJ, Zhao K, et al. The Role of Artificial Intelligence in Chronic Rhinosinusitis: A Scoping Review. Int Forum Allergy Rhinol. 2025. PMID: 41376460. doi:10.1002/alr.70078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。